Ethical Challenges of Consent in Data Sharing

Sponsor
University of Oxford (Other)
Overall Status
Completed
CT.gov ID
NCT03346720
Collaborator
(none)
40
3
6.1
13.3
2.2

Study Details

Study Description

Brief Summary

In recent years, Mahidol Oxford Tropical Medicine Research Unit (MORU) has coordinated some of the largest international studies involving many sites in low-income and hard-to-reach settings. It has been our policy for many years to support sharing of data across collaborative research networks in order to maximize their utility. However there is increasing support from research funders, regulatory agencies and journals for sharing individual-level data from genomic, medical and public health research beyond research collaborations. A number of potential advantages of sharing individual level data from clinical and public health research have been identified in the literature. These include maximizing the utility of data, allowing verification of research results, and minimizing the burdens and costs of unnecessary duplication of research. In low- and middle-income settings it may be particularly important to effectively share data to maximize its utility and enable timely responses to important public health issues such as resistance to antimalarial treatments. Many authors have called for data sharing to be carefully curated, to minimize potential harms including breaches of privacy, the publication of poor quality or biased secondary research, and insufficient acknowledgment of the contribution of researchers generating datasets. In low- and middle-income settings, the need for data sharing policies and processes to promote equitable use of data, including the development of sustainable capacity to both share and analyse datasets, has been recognized.

It is foreseeable that the impact of this policy will be significant both practically and ethically. In the practical sense, there have already been changes in our data management processes and resources, clinical trial agreements and negotiations with collaborators. Ethically, this policy has impact on the consent process which includes the increasing use of broad consent, the changes in the language of information sheets, study protocols and ethics application documents and the actual consent taking by research staff.

Now that that these new data-sharing mechanisms have been put in place there is a need to evaluate their impact on practice. The aim of this study is to identify and analyse ethical challenges related to consent following implementation of a new data sharing policy with the aim of refining the data sharing policy and its related consent processes

Condition or Disease Intervention/Treatment Phase
  • Other: Semi-structured interviews
  • Other: Focus group discussions (FGDs)

Study Design

Study Type:
Observational
Actual Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Ethical Challenges Related to Consent Following Implementation of a New Data Sharing Policy
Actual Study Start Date :
Feb 1, 2017
Actual Primary Completion Date :
Aug 7, 2017
Actual Study Completion Date :
Aug 7, 2017

Arms and Interventions

Arm Intervention/Treatment
Participants recruited into biomedical research

Participants recruited into biomedical research where data collected may be shared with the wider research community.

Other: Semi-structured interviews
These interviews will be conducted following an interview guide. Interviews will be conducted in English or Thai at a place convenient and familiar to the interviewee. It is estimated that each interview will last between 45 minutes to an hour.

Other: Focus group discussions (FGDs)
These will be conducted following an interview guide. FGDs will be conducted in English or Thai. In addition, a note taker will be present to take notes. FGDs will take place at a place convenient and familiar to the participants. It is estimated that each FGD will last between 1 to 1.5 hours. FGDs will typically consist of homogenous groups e.g. study nurses.

Frontline research staff

Frontline research staff directly involved in obtaining consent from participants in the above studies e.g. study nurses, investigators

Other: Semi-structured interviews
These interviews will be conducted following an interview guide. Interviews will be conducted in English or Thai at a place convenient and familiar to the interviewee. It is estimated that each interview will last between 45 minutes to an hour.

Other: Focus group discussions (FGDs)
These will be conducted following an interview guide. FGDs will be conducted in English or Thai. In addition, a note taker will be present to take notes. FGDs will take place at a place convenient and familiar to the participants. It is estimated that each FGD will last between 1 to 1.5 hours. FGDs will typically consist of homogenous groups e.g. study nurses.

Research related staff and other stakeholders

Research related staff and other stakeholders involved in the implementation of the data sharing policy e.g. study managers, data access committee members, ethics committee members, study nurses, investigators, research collaborators, data managers and other clinical trials support staff.

Other: Semi-structured interviews
These interviews will be conducted following an interview guide. Interviews will be conducted in English or Thai at a place convenient and familiar to the interviewee. It is estimated that each interview will last between 45 minutes to an hour.

Other: Focus group discussions (FGDs)
These will be conducted following an interview guide. FGDs will be conducted in English or Thai. In addition, a note taker will be present to take notes. FGDs will take place at a place convenient and familiar to the participants. It is estimated that each FGD will last between 1 to 1.5 hours. FGDs will typically consist of homogenous groups e.g. study nurses.

Community advisory board members

Community advisory board members and other community members

Other: Semi-structured interviews
These interviews will be conducted following an interview guide. Interviews will be conducted in English or Thai at a place convenient and familiar to the interviewee. It is estimated that each interview will last between 45 minutes to an hour.

Other: Focus group discussions (FGDs)
These will be conducted following an interview guide. FGDs will be conducted in English or Thai. In addition, a note taker will be present to take notes. FGDs will take place at a place convenient and familiar to the participants. It is estimated that each FGD will last between 1 to 1.5 hours. FGDs will typically consist of homogenous groups e.g. study nurses.

Outcome Measures

Primary Outcome Measures

  1. The opinion of ethical challenges in consent process under a new data sharing policy [1 year]

Secondary Outcome Measures

  1. The opinion of participants recruited in primary research with information presented to potential participations in future research studies about data sharing [1 year]

  2. The views of stakeholders with broad consent [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participant is willing and able to give informed consent for participation in the study.

  • Male or female, aged 18 years or above.

  • Able to speak and understand Thai, English, Burmese or Karen

Exclusion Criteria:
  • Lack of relevant experience or expertise

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shoklo Malaria Research Unit, Mae Sot Mae Sot Tak Thailand
2 Hospital for tropical diseases, Faculty of Tropical Medicine, Mahidol University Bangkok Thailand 10400
3 Mahidol-Oxford Tropical Medicine Research Unit (MORU) Office Bangkok Thailand 10400

Sponsors and Collaborators

  • University of Oxford

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Oxford
ClinicalTrials.gov Identifier:
NCT03346720
Other Study ID Numbers:
  • BE1601
First Posted:
Nov 17, 2017
Last Update Posted:
Jun 20, 2018
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Oxford

Study Results

No Results Posted as of Jun 20, 2018